摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(6-巯基己氧基)苄醇 | 912617-71-1

中文名称
4-(6-巯基己氧基)苄醇
中文别名
——
英文名称
{4-[(6-Sulfanylhexyl)oxy]phenyl}methanol
英文别名
[4-(6-sulfanylhexoxy)phenyl]methanol
4-(6-巯基己氧基)苄醇化学式
CAS
912617-71-1
化学式
C13H20O2S
mdl
MFCD08705275
分子量
240.36
InChiKey
HHHRERFRNRFXOV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    44-49 °C
  • 沸点:
    397.5±27.0 °C(Predicted)
  • 密度:
    1.073±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    16
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.538
  • 拓扑面积:
    30.5
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • WGK Germany:
    3

文献信息

  • DISPERSION
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP3305853A1
    公开(公告)日:2018-04-11
    A dispersion which contains a dispersant and particles selected from among metal particles and metal oxide particles, and which is characterized in that: the dispersant has a chemical structure that is able to be bonded or adsorbed to the particles; and the dispersant contains a low-molecular-weight dispersant that has at least one peak within a molecular weight region of 31 or more but less than 1,000 in the molecular weight distribution curve in terms of polyethylene glycol as determined by gel permeation chromatography and a high-molecular-weight dispersant that has at least one peak within a molecular weight region of 1,000 or more but 40,000 or less in the above-described molecular weight distribution curve.
    一种分散剂,它含有一种分散剂和选自属颗粒和金属氧化物颗粒的颗粒,其特征在于分散剂的化学结构能与颗粒结合或吸附;分散剂含有一种低分子量分散剂,该分散剂在凝胶渗透色谱法测定的聚乙二醇分子量分布曲线中,至少有一个峰值在 31 或以上但小于 1,000 的分子量区域内;还含有一种高分子量分散剂,该分散剂在上述分子量分布曲线中,至少有一个峰值在 1,000 或以上但小于 40,000 的分子量区域内。
  • Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
    申请人:Microbion Corporation
    公开号:US10835510B2
    公开(公告)日:2020-11-17
    Compositions and methods, including novel homogeneous microparticulate suspensions, are described for treating acute wounds, chronic wounds and/or a wound or epithelial tissue surface that contains bacterial biofilm, including unexpected synergy between bismuth-thiol (BT) compounds and certain antibiotics, to provide topical formulations including antiseptic formulations, for management and promotion of wound healing and in particular infected wounds. Previously unpredicted antibacterial properties and anti-biofilm properties of disclosed BT compounds and BT compound-plus-antibiotic combinations are also described, including preferential efficacies of certain such compositions for treating gram-positive bacterial infections, and distinct preferential efficacies of certain such compositions for treating gram-negative bacterial infections.
    本文描述了用于治疗急性伤口、慢性伤口和/或含有细菌生物膜的伤口或上皮组织表面的组合物和方法,包括新型均匀微粒悬浮液,包括醇(BT)化合物与某些抗生素之间意想不到的协同作用,以提供局部制剂,包括防腐制剂,用于管理和促进伤口愈合,特别是感染伤口。此外,还描述了已公开的 BT 化合物和 BT 化合物加抗生素组合物以前未曾预料到的抗菌特性和抗生物膜特性,包括某些此类组合物治疗革兰氏阳性细菌感染的优先功效,以及某些此类组合物治疗革兰氏阴性细菌感染的独特优先功效。
  • Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
    申请人:Microbion Corporation
    公开号:US10960012B2
    公开(公告)日:2021-03-30
    Compositions and methods, including novel homogeneous microparticulate suspensions, are described for treating natural surfaces that contain bacterial biofilm, including unexpected synergy or enhancing effects between bismuth-thiol (BT) compounds and certain antibiotics, to provide formulations including antiseptic formulations. Previously unpredicted antibacterial properties and anti-biofilm properties of disclosed BT compounds and BT compound-plus-antibiotic combinations are also described, including preferential efficacies of certain such compositions for treating certain gram-positive bacterial infections, and distinct preferential efficacies of certain such compositions for treating certain gram-negative bacterial infections.
    介绍了用于处理含有细菌生物膜的天然表面的组合物和方法,包括新型均质微粒悬浮剂,包括醇(BT)化合物和某些抗生素之间意想不到的协同作用或增强效果,以提供包括防腐制剂在内的配方。此外,还描述了所公开的 BT 化合物和 BT 化合物加抗生素组合物以前未曾预料到的抗菌特性和抗生物膜特性,包括某些此类组合物治疗某些革兰氏阳性细菌感染的优先功效,以及某些此类组合物治疗某些革兰氏阴性细菌感染的独特优先功效。
  • Covalent treatment with thiols of keratin-containing materials
    申请人:Living Proof, Inc.
    公开号:US10993903B2
    公开(公告)日:2021-05-04
    Disclosed are methods of preparing thiol keratin-containing materials, comprising applying a mixture comprising one or more thiol compounds and a catalyst. Methods of preparing cross-linked keratin-containing materials by applying a mixture comprising one or more thiol compounds and an oxidizing agent are also disclosed. Methods of grafting monomeric and polymeric materials on keratin-containing materials to provide a covalent coating on keratin-containing materials are disclosed. A mixture comprising one or more thiol compounds is applied to the keratin-containing material sample. The keratin-containing material sample then comprises a plurality of free thiol groups. A monomer is optionally applied to the keratin-containing material sample to form a plurality of covalent bonds between the free thiol groups and the monomers. The disclosed grafting methods can be carried out with or without catalyst.
    本发明公开了制备含醇角蛋白材料的方法,包括使用由一种或多种醇化合物和催化剂组成的混合物。还公开了通过使用由一种或多种醇化合物和氧化剂组成的混合物制备交联含角蛋白材料的方法。公开了在含角蛋白材料上接枝单体和聚合物材料以在含角蛋白材料上提供共价涂层的方法。将包含一种或多种醇化合物的混合物涂抹在含角蛋白材料样品上。这样,含角蛋白材料样品就含有多个游离醇基团。可选择将单体应用于含角蛋白材料样品,以在游离醇基团和单体之间形成多个共价键。所公开的接枝方法可在使用或不使用催化剂的情况下进行。
  • DETECTION OF CANCER MARKERS
    申请人:Polytechnic University
    公开号:EP2147298A1
    公开(公告)日:2010-01-27
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯